Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy
Year: 2010
Type: review
Abstract: Age-related cerebrovascular dysfunction contributes to ischemic stroke, intracerebral hemorrhages (ICHs), microbleeds, cerebral amyloid angiopathy (CAA), and cognitive decline. Importantly, there is increasing recognition that this dysfunction plays a critical secondary role in many neurodegenerative diseases, including Alzheimer's disease (AD). Atherosclerosis, hypertension, and CAA are the most common causes of blood-brain barrier (BBB) lesions. The accumulation of amyloid beta (Aβ) in the cerebrovascular system is a significant risk factor for ICH and has been linked to endothelial transport failure and blockage of perivascular drainage. Moreover, recent anti-Aβ immunotherapy clinical trials demonstrated efficient clearance of parenchymal amyloid deposits but have been plagued by CAA-associated adverse events. Although management of hypertension and atherosclerosis can reduce the incidence of ICH, there are currently no approved therapies for attenuating CAA. Thus, there is a critical need for new strategies that improve BBB function and limit the development of β-amyloidosis in the cerebral vasculature.
Authors: Vitaly Vasilevko, Giselle F. Passos, Daniel Quiring, Elizabeth Head, Richard C. Kim, Mark Fisher, David H. Cribbs
Institution: University of California, Irvine
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Behavioral and Neural Plasticity in the Aged, G1883455192, G215741508, G240390789, G2425907836, G3759868739, The Alzheimer's Disease Research Center at the University of California, Irvine, Multiple Approaches to Abeta Vaccination in Animal Models, Combining AD Epitope Vaccine with Innate Immunity, Multiple Approaches to Abeta Vaccination in Animal Models, G9000052124, G9000119970
OpenAlex ID: W1935472980
